Ionis Pharmaceuticals Total Risk Alpha

IONS Stock  USD 72.70  3.02  4.33%   
Technical inputs supporting the Total Risk Alpha indicator for Ionis Pharmaceuticals are shown here. Availability can differ across markets, exchanges, and instruments. Ionis Pharmaceuticals has a market cap of 11.51 B, operating margin of -105.47%, current ratio of 8.18. For allocation context, review Risk vs Return Analysis. Portfolio tools allow users to monitor Ionis Pharmaceuticals alongside other positions. All metrics are derived from available inputs and shown for reference. Broader economic conditions can influence Ionis Pharmaceuticals's company valuation — related indicators include signals in inflation.
For information on how to trade Ionis Stock refer to our How to Invest in Ionis Pharmaceuticals guide. It explains the process for buying and trading Ionis Stock effectively.
Ionis Pharmaceuticals has current Total Risk Alpha of 0.0435. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.

Total Risk Alpha

 = 

RFR + (ER[b] - ER[a])

x

STD[a] / STD[b]

 = 
0.0435
ER[a] = Expected return on investing in Ionis Pharmaceuticals
ER[b] = Expected return on market index or selected benchmark
STD[a] =   Standard Deviation of returns on Ionis Pharmaceuticals
STD[b] = Standard Deviation of selected market or benchmark
RFR = Risk Free Rate of return. Typically T-Bill Rate

Total Risk Alpha Peers Comparison

Total Risk Alpha Relative To Other Indicators

Ionis Pharmaceuticals is rated below average in total risk alpha relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors yielding 210.78 of Maximum Drawdown per Total Risk Alpha. For Ionis Pharmaceuticals, Maximum Drawdown stands at 210.78 times Total Risk Alpha
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund. Compare Ionis Pharmaceuticals to Peers

Other Technical Indicators